Skip to main content
. 2023 Jun 21;21:404. doi: 10.1186/s12967-023-04277-2

Table 2.

Univariate and multivariate COX analysis of characteristics extracted from SEER database

Univariate COX analysis Multivariate COX analysis
OS BCSS OS BCSS
HR 95%CI P Value HR 95%CI P Value HR 95%CI P Value HR 95%CI P Value
Age at diagnosis
 < 40 Reference Reference Reference Reference
 40–49 1.292 1.006–1.660 * 1.201 0.922–1.564 0.175 1.322 0.646–2.706 0.444 1.105 0.521–2.279 0.791
 50–59 1.423 1.132–1.788 ** 1.371 1.080–1.740 ** 2.232 1.180–4.221 * 2.293 1.165–4.101 *
 60–69 1.674 1.336–2.099 *** 1.608 1.270–2.037 *** 1.900 1.030–3.620 * 1.746 1.002–3.181 *
 70–79 2.291 1.802–2.911 *** 2.175 1.692–2.796 *** 3.336 1.636–6.805 *** 3.737 1.845–7.569 ***
 80 +  2.710 2.056–3.574 *** 2.448 1.824–3.286 *** 1.908 0.764–4.767 0.166 2.282 1.061–5.617 *
Months from diagnosis to therapy
 0 month Reference Reference Reference Reference
 ≥ 1 month 0.842 0.753–0.942 ** 0.846 0.751–0.953 ** 0.799 0.580–1.088 0.159 0.782 0.569–1.075 0.128
Subtype
 HR + /HER2- Reference Reference Reference Reference
 HR + /HER2 +  0.772 0.659–0.904 ** 0.790 0.668–0.934 ** 0.900 0.559–1.497 0.674 0.860 0.516–1.435 0.564
 HR-/HER2 +  0.962 0.813–1.138 0.653 0.983 0.822–1.174 0.846 2.163 1.407–3.606 *** 2.029 1.251–3.290 **
 HR-/HER2- 1.744 1.511–2.015 *** 1.830 1.572–2.129 *** 3.575 2.380–5.771 *** 3.369 2.150–5.278 ***
Race
 White Reference Reference Reference Reference
 Black 1.266 1.107–1.448 *** 1.222 1.057–1.412 ** 1.002 0.601–1.496 0.994 0.936 0.581–1.510 0.787
 Other 0.883 0.735–1.061 0.185 0.812 0.663–0.993 * 0.824 0.480–1.541 0.519 0.754 0.411–1.382 0.361
Histological type
 IDC Reference Reference Reference Reference
 ILC 0.992 0.779–1.262 0.947 0.955 0.738–1.236 0.728 2.794 1.266–6.197 * 2.838 1.297–6.214 **
 Mixed 0.887 0.679–1.158 0.449 0.857 0.644–1.139 0.287 1.040 0.536–2.027 0.908 0.934 0.468–1.862 0.846
 Other 1.354 1.209–1.516 *** 1.225 1.083–1.386 ** 1.422 0.784–2.724 0.270 1.015 0.484–2.128 0.970
Marital status
 Married Reference Reference Reference Reference
 Singled 1.262 1.111–1.435 *** 1.251 1.091–1.435 ** 1.793 1.198–2.695 ** 1.879 1.253–2.819 **
 Widow/divorced/other 1.519 1.351–1.706 *** 1.531 1.353–1.734 *** 1.571 1.034–2.253 * 1.543 1.044–2.279 *
T Stage
 T1 Reference Reference Reference Reference
 T2 1.064 0.878–1.291 0.526 1.146 0.931–1.412 0.199 1.839 0.986–3.360 0.051 1.915 0.998–3.650 0.056
 T3 1.137 0.921–1.405 0.233 1.231 0.981–1.545 0.073 1.652 0.784–3.289 0.168 1.543 0.756–3.146 0.233
 T4 1.248 1.042–1.495 * 1.337 1.099–1.626 ** 1.918 1.025–3.419 * 1.910 1.023–3.566 *
N Stage
 N0 Reference Reference refereNce Reference
 N1 0.934 0.815–1.071 0.327 0.951 0.822–1.100 0.502 0.979 0.646–1.584 0.925 / / /
 N2 0.788 0.645–0.963 * 0.834 0.675–1.029 0.09 0.864 0.411–1.702 0.687 / / /
 N3 0.921 0.777–1.092 0.342 0.962 0.804–1.152 0.676 1.171 0.718–1.907 0.524 / / /
Grade
Well differentiated Reference Reference Reference Reference
 Moderately differentiated 1.175 0.871–1.586 0.291 1.266 0.914–1.754 0.156 0.906 0.423–1.939 0.799 0.820 0.370–1.820 0.626
 Poorly differentiated 1.435 1.072–1.921 * 1.561 1.137–2.145 ** 1.140 0.529–2.458 0.738 1.177 0.530–2.618 0.689
Median household income(inflation adjusted)
 < 40,000$ Reference Reference Reference Reference
 40,000–49,999$ 1.055 0.823–1.352 0.676 1.006 0.774–1.308 0.965 0.559 0.254–1.230 0.148 0.604 0.277–1.320 0.207
 50,000–59,999$ 1.053 0.888–1.249 0.477 1.058 0.823–1.361 0.659 0.728 0.357–1.488 0.385 0.733 0.356–1.506 0.398
 60,000–69,999$ 0.931 0.805–1.076 0.748 0.936 0.742–1.181 0.579 0.724 0.381–1.377 0.325 0.651 0.341–1.243 0.193
 70,000$ +  0.760 0.656–0.879 * 0.751 0.595–0.948 * 0.522 0.271–1.006 0.052 0.523 0.273–0.999 *
Chemotherapy
 No/unknown Reference Reference Reference Reference
 Yes 0.454 0.410–0.502 *** 0.477 0.428–0.531 *** 0.386 0.267–0.558 *** 0.436 0.301–0.637 ***
Radiotherapy
 No/unknown Reference Reference Reference Reference
 Yes 0.629 0.568–0.697 *** 0.667 0.598–0.744 *** 0.721 0.499–1.042 0.082 0.753 0.520–1.092 0.135
Surgery
 No/unknown Reference Reference Reference Reference
 Yes 0.619 0.529–0.724 *** 0.615 0.520–0.727 *** 0.693 0.430–1.117 0.132 0.742 0.464–1.186 0.212
Bone metastases
 No/unknown Reference Reference Reference Reference
 Yes 0.956 0.859–1.063 0.407 1.002 0.894–1.123 0.973 / / / / / /
Liver metastases
 No/unknown Reference Reference Reference Reference
 Yes 1.290 1.159–1.436 *** 1.283 1.144–1.438 *** 1.286 0.892–1.860 0.179 1.264 0.877–1.823 0.209
Lung metastases
 No/unknown Reference Reference Reference Reference
 Yes 1.434 1.294–1.589 *** 1.426 1.278–1.592 *** 1.606 1.157–2.230 ** 1.698 1.219–2.365 **
Distant Lymph nodes metastases
 No/unknown Reference Reference Reference Reference
 Yes 1.128 0.942–1.352 0.190 1.093 0.900–1.327 0.368 / / / / / /
Distant other metastases
 No/unknown Reference Reference Reference Reference
 Yes 1.331 1.101–1.609 ** 1.322 1.079–1.620 ** 1.195 0.829–1.723 0.339 1.216 0.842–1.757 0.296

*P < 0.05,

**P < 0.01,

***P < 0.001